{"10": {"": ["Cash and cash equivalents", "Cash at the end of the reporting period"]}, "11": {"": ["Other financial assets", "Other financial assets", "Unsecured Reserve Facility"]}, "12": {"": ["Inventories"]}, "13": {"": ["Investment in Joint Venture"]}, "14": {"": ["Property, plant and equipment"]}, "15": {"": ["Right of use assets"]}, "16": {"": ["Development"]}, "17": {"": ["Exploration and evaluation"]}, "18": {"": ["Loans and borrowings", "Loans and borrowings", "Net working capital facility drawdowns", "Repayment of Rasp loan"]}, "19": {"": ["Other financial liabilities"]}, "20": {"": ["Provisions", "Provisions"]}, "21": {"": ["Share capital", "Issue of ordinary shares"]}, "5": {"": ["Finance revenue"]}, "6": {"": ["Other income", "Proceeds on sale of subsidiary company"]}, "9": {"": ["Impairment loss"]}, "7": {"": ["Finance costs"]}, "8": {"": ["Income tax benefit"]}}